Compound class:
Synthetic organic
Comment: This compound was discovered as a noncovalent coronavirus Mpro inhibitor in a virtual screening campaign of >200 million fragments, followed by crystallographic screening and hit-to-lead optimisation [1]. Binding to the SARS-CoV-2 Mpro and inhibition of its protease activity were confirmed in in vitro assays.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 19 did not inhibit a set of human proteases (cathepsins K, D, B, L, thrombin, caspase-2, elastase, calpain 1, trypsin), and its cytotoxicity was low against human Vero E6 and Huh7 cells [1]. It inhibits SARS-CoV-2 replication in Vero E6 cells with an EC50 of 44 nM. |
Selectivity at other protein targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|